Skip to main content

Main menu

  • About Us
    • Leadership
    • Our Team
    • Vision, Mission and Values
    • Health and Economic Impact
    • Research Impact Video
    • Strategic Plan
  • Our Research
    • Research Focus
      • Brain Health
      • Cancer
      • Digital Health and Artificial Intelligence
      • Heart Health
      • Healthy Aging and Mobility
      • Immune System
      • Injury and Rehabilitation
      • Lung Health
      • Mental Health and Substance Use
    • Research Centres and Programs
      • BC Centre on Substance Use
      • Centre for Aging SMART
      • Centre for Clinical Epidemiology and Evaluation
      • Centre for Lung Health
      • Dilawri Cardiovascular Institute
      • Djavad Mowafaghian Centre for Brain Health
      • Immunity and Infection Research Centre
      • International Collaboration On Repair Discoveries
      • M. H. Mohseni Institute of Urologic Sciences
      • Ovarian Cancer Research Centre
      • Community Research Program
      • Emergency Medicine Research Program
      • Hematology Research Program
      • Skin Research Program
      • Other Research Focus Areas
    • News and Stories
    • Researcher Directory
    • Events and Workshops
  • Research Services
    • New to VCHRI
      • Working at VCHRI
      • Regulations and Training
      • Membership with VCHRI
      • Learning and Development
    • Starting Your Project
      • Research Facilitation
      • Awards and Funding
      • Grant Management
      • Operational Approval
      • CST Cerner
    • Developing Your Project
      • Clinical Trials Administration
      • Clinical Research Unit
      • Research Privacy
      • Financial Policies and Procedures
    • Additional Support
      • Indigenous Health Research Unit
      • VCH-VCHRI AI Hub
      • Communications and Media Relations
      • Study Recruitment Support
      • Innovation and Industry Partnership
    • Internal Awards
    • Clinical Research
    • Indigenous Research
  • Participate in Research
    • Reasons to Participate
    • Participant Stories
    • Find a Study
    • Recruitment Support

User menu

  • Log in

Breadcrumb

  1. Home
  2. Our Research
  3. News and Stories
  4. Specialized AI could elevate diabetes-related blindness risk prevention

Specialized AI could elevate diabetes-related blindness risk prevention

Stories Jan 5, 2026 4 minutes

Preliminary findings indicate that key sex differences in diabetic retinopathy disease presentation could be essential for precision diagnostics.

Sex differences could play a key role in diagnosing diabetic retinopathy, according to the results of a groundbreaking study led by Vancouver Coastal Health Research Institute researcher Dr. Ipek Oruc. A condition that puts patients at risk of blindness, diabetic retinopathy may be more likely to progress along a given pathway depending on whether a patient was born male or female. 

“The lack of sex- and gender-specific medical guidelines for diabetic retinopathy highlights the need for more research into the underlying mechanisms of these differences.”

Diabetic retinopathy is the most common cause of blindness associated with diabetes, affecting around one million Canadians. The condition is characterized by changes to tiny blood vessels at the back of the eye. 

In the early stages, symptoms of the disease may go unnoticed, such as with mild to moderate non-proliferative diabetic retinopathy. However, once the condition advances, various vision-threatening complications may arise. Leakage from damaged blood vessels can lead to eye swelling — called macular edema — which causes vision loss primarily affecting central vision.

As the disease progresses to proliferative diabetic retinopathy, abnormal new blood vessel growth leads to complications such as vitreous haemorrhage, retinal detachment, neovascular glaucoma and severe vision loss.  

“If left untreated, around half of high-risk non-proliferative patients will experience progression to proliferative diabetic retinopathy within a year — making it particularly crucial to identify and manage the disease early.”

“Regular monitoring is crucial for detecting early signs of diabetic retinopathy and to prevent its progression to moderate or severe disease,” says Oruc. “However, aside from considerations during pregnancy — when females are at higher risk for progression — sex is not presently factored into disease diagnosis, management or treatment.”

Researchers trained, validated and tested an artificial intelligence (AI) algorithm on a data set of 2,967 fundus images from 1,491 female and 1,476 male patients with diabetic retinopathy. The fundus is the inner area at the back of the eye comprising the retina, optic disc, fovea, macula and blood vessels. 

Dr. Ipek Oruc is the director of the NOVA Lab and a researcher with the Djavad Mowafaghian Centre for Brain Health. She is also an investigator with the Data Science Institute, an associate member of the School of Biomedical Engineering and an associate professor in the Department of Ophthalmology and Visual Sciences at the University of British Columbia.

The algorithm was trained to classify patient sex from retinal images of people with diabetic retinopathy. Male and female groups were matched for age, ethnicity, severity of diabetic retinopathy and hemoglobin A1c levels — a measure of blood sugar in the body — to prevent the model from using these potentially confounding variables when classifying a patient’s sex.

Oruc and her team used convolutional neural networks (CNNs) — AI algorithms specializing in image classification — to identify patterns of diabetic retinopathy presentation in the images. This approach builds on the team’s prior research on the classification of retinas by sex.

“CNNs can find patterns in images not readily apparent to the human eye, even among experts in the field.”

One of the research team’s central objectives was to find an empirical method to identify potential differences in how diabetic retinopathy manifests in females and males. 

Sex-specific diagnostics could enhance diabetic retinopathy management 

To see whether there were sex-specific disease characteristics of diabetic retinopathy, Oruc and her team used Guided Grad-CAM saliency maps — an explainable-AI technique that can peer into the often mysterious ‘black box’ of CNNs. While CNNs can identify unique features in a series of images, the explanatory AI built into Guided Grad-CAM saliency maps helps researchers understand how the CNN arrived at its conclusions. 

“For example, if we were to use explainable AI to identify what distinguishes a celebrity from other people, it may highlight the celebrity’s nose and mouth as important features that set that celebrity apart,” Oruc says. 

(L-R) A saliency map of the original fundus images from male and female patients, Guided Grad-CAM images (middle) and colour-coded images that emphasize areas of disease prevalence.

The Guided Grad-CAM saliency maps showed that the CNN focused on the macula in female fundus images and the optic disc and peripheral branching vasculature from the optic nerve in male fundus images.

“This pattern differed noticeably from the saliency maps generated by CNNs trained on healthy eyes, which did not highlight these particular regions, indicating that diabetic retinopathy may manifest differently by sex,” says Oruc.

The locations in the fundus emphasized by the model raise the hypothesis that women may be at higher risk for developing macular edema — a leading cause of blindness in diabetic retinopathy — while men may be at greater risk for more severe proliferative diabetic retinopathy, Oruc says. 

“However, further research is needed to validate this hypothesis,” she adds, which is why her team is presently conducting a follow-up study. 

“If confirmed, sex-specific disease indicators could have significant implications for the diagnosis, management and treatment of diabetic retinopathy.” 

The research team’s application of CNNs — interpreted using Guided Grad-CAM — was able to achieve a high level of accuracy using a smaller dataset for training the algorithm than is typical, Oruc notes. “This is particularly important, as large datasets are more costly and time-consuming.” 

“The success of this approach with a small dataset puts studies like ours within reach of other research teams with limited resources.”  

Researchers

Ipek Oruc

Related Articles

Timely wrap-around support for people with type 1 diabetes

Ask an expert: How can I manage my type 1 diabetes?

Personalized support could lead to better management of type 2 diabetes

Share:

  • Facebook
  • Linkedin
  • Bluesky
  • Email

Related Research Centres/Programs

Djavad Mowafaghian Centre for Brain Health

Get the latest research headlines in your inbox

Subscribe

Recent News and Stories

Type
Announcement

Reflecting on resilience, renewal and the road ahead

Dec 8, 2025 seasonal
Type
Stories

Canadians are at high risk of kidney stones: Dietary interventions could help

Dec 4, 2025 kidney, preventative, diet
Type
Announcement

Vancouver Coastal Health Research Institute recognized as one of Canada’s leading hospital-based research institutes

Dec 4, 2025
See more news

Get updates!

Join our newsletter mailing list to stay up to date on features and releases.

Subscribe

Quick Links

  • News and Stories
  • Careers
  • Events
  • Media Enquiries

Follow Us

  • LinkedIn
  • Bluesky
  • YouTube

© 2026 VCHRI. All rights reserved.

  • Contact
  • Privacy Policy